Nanocarriers in Neurodegenerative Disorders by Mohamed, Wael;

Therapeutic Hopes and Hypes

GET 20% OFF
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.

Publisher's listprice GBP 165.00
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

78 828 Ft (75 075 Ft + 5% VAT)
Discount 20% (cc. 15 766 Ft off)
Discounted price 63 063 Ft (60 060 Ft + 5% VAT)

78 828 Ft

Availability

Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.

Product details:

Edition number 1
Publisher CRC Press
Date of Publication 30 September 2024

ISBN 9781032467955
Binding Hardback
No. of pages366 pages
Size 280x210 mm
Weight 840 g
Language English
Illustrations 33 Illustrations, black & white; 22 Illustrations, color; 19 Halftones, black & white; 18 Halftones, color; 14 Line drawings, black & white; 4 Line drawings, color; 19 Tables, black & white

Short description:

This book aims to furnish readers with a thorough understanding of the clinical application of nanocarrier systems for treating neurodegenerative disorders, encompassing the latest developments, challenges, safety concerns, toxicity issues, regulatory considerations, future prospects, and limitations.

Long description:

Due to the lack of secure, efficient, and patient-friendly therapies for neurodegenerative disorders, there is a rising demand for innovative approaches. Despite the limited number of nanocarriers approved for human use, they have demonstrated significant potential in preclinical and, in some instances, clinical trials. In alignment with this objective, the chapters of the book are structured to offer a comprehensive overview of recent advancements in medication and dosage form development, specifically emphasizing the nanoparticulate system for targeting the brain. This book aims to furnish readers with a thorough understanding of the clinical application of nanocarrier systems for treating neurodegenerative disorders, encompassing the latest developments, challenges, safety concerns, toxicity issues, regulatory considerations, prospects, and limitations. Individuals in academia, the scientific community, business, and education seeking a more effective approach to target the brain will find valuable insights in this resource.

Key Features

Provides a comparative perspective of various nanocarrier systems, therefore facilitating the researcher's selection of appropriate nanoparticulate carriers